DexCom Total Other Income Expense Net from 2010 to 2026

DC4 Stock  EUR 61.93  0.59  0.96%   
DexCom's Total Other Income Expense Net is increasing over the last several years with slightly volatile swings. Total Other Income Expense Net is estimated to finish at about 86.3 M this year. During the period from 2010 to 2026 DexCom Inc Total Other Income Expense Net regressed destribution of quarterly values had mean deviationof  25,081,246 and mean square error of 1016.8 T. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2016-12-31
Previous Quarter
81.8 M
Current Value
-1.6 M
Quarterly Volatility
18.3 M
 
Covid
 
Interest Hikes
Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 31.7 M, Selling General Administrative of 742.9 M or Total Revenue of 4.9 B, as well as many indicators such as . DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.
  
This module can also supplement various DexCom Technical models . Check out the analysis of DexCom Correlation against competitors.
The Total Other Income Expense Net trend for DexCom Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether DexCom is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest DexCom's Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of DexCom Inc over the last few years. It is DexCom's Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Slightly volatile
   Total Other Income Expense Net   
       Timeline  

DexCom Total Other Income Expense Net Regression Statistics

Arithmetic Mean11,806,471
Coefficient Of Variation297.92
Mean Deviation25,081,246
Median(800,000)
Standard Deviation35,173,622
Sample Variance1237.2T
Range123.2M
R-Value0.48
Mean Square Error1016.8T
R-Squared0.23
Significance0.05
Slope3,336,716
Total Sum of Squares19794.9T

DexCom Total Other Income Expense Net History

202686.3 M
202582.2 M
2024-6.2 M
2023-2 M
2022200 K
20218.4 M
2020-5.9 M

About DexCom Financial Statements

DexCom stakeholders use historical fundamental indicators, such as DexCom's Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Although DexCom investors may analyze each financial statement separately, they are all interrelated. For example, changes in DexCom's assets and liabilities are reflected in the revenues and expenses on DexCom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in DexCom Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense Net82.2 M86.3 M

Currently Active Assets on Macroaxis

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out the analysis of DexCom Correlation against competitors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.